Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Rapid early mobilization with seated cycling for people with recent traumatic spinal cord injury (PROMPT-SCI II)

Official title: Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial: Initiating Early Acute Cycling Within the First Days After Spinal Cord Injury to Decrease Complications and Improve Neurofunctional Recovery

Run by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal · NCT07472985 · Data updated 2026-11-12

This study will test whether starting seated cycling within days after a traumatic spinal cord injury is safe and helps improve recovery and reduce complications in adults.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment102 (estimated)
SponsorCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedMarch 9, 2026
Main results expectedAugust 31, 2031
Study endsDecember 31, 2031
Registry record updatedOctober 23, 2026
Trial IDNCT07472985 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with recent non-penetrating traumatic spinal cord injury (AIS grades A–C) affecting levels C0–L2 who had spine surgery within 48 hours and are medically stable for seated cycling are ideal candidates.

Probably not a fit

Patients who are intubated or mechanically ventilated, medically unstable, have moderate-to-severe traumatic brain injury, weight-bearing or mobilization restrictions, or other conditions that prevent safe cycling are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PROMPT-SCI II is a single-center longitudinal cohort study that starts seated cycling early during acute care to see if longer-duration, upright cycling improves neurofunctional recovery and lowers immobilization complications. Participants are adults with non-penetrating traumatic SCI (AIS A–C) with neurological level C0–L2 who had spine surgery within 48 hours and are medically stable for cycling. The intervention is activity-based seated cycling begun in the first days after injury and continued through acute hospitalization, with monitoring for adverse events and completion rates. Outcomes include safety, complication rates, and measures of motor and sensory recovery compared to expected recovery trajectories.

Why it matters

Potential benefit: If successful, early seated cycling could reduce complications from immobilization and help improve neurological recovery and independence after traumatic SCI.

How similar studies have gone: A prior PROMPT-SCI study showed early in-bed cycling was safe, reduced some complications, and activated paralyzed muscles but did not demonstrate neurofunctional benefit, while preclinical studies suggest early exercise can aid recovery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* adults 18 years or older with non-penetrating traumatic SCI
* SCI severity AIS grade A (complete injury with no motor or sensory function below lesion), B (sensory but no motor function preserved) or C (motor function preserved with most key muscles unable to move against gravity)
* NLI between C0 and L2; and spine surgery performed within 48 hours of SCI

Exclusion Criteria:

* intubated and mechanically ventilated
* conditions interfering with patient safety or ability to undergo cycling
* body mass index 40 kg/m2 or less (to prevent "frog leg" position during cycling)
* moderate or severe traumatic brain injury
* hemodynamic instability
* pelvic or lower extremity
* injury with weight-bearing or mobilization restrictions

Where it's running

  • Hopital du Sacre-Coeur de Montreal
    Montreal, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Jean-Marc Mac-Thiong, MD, PhD — Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
  • Study coordinator: Jean-Marc Mac-Thiong, MD, PhD
  • Email: jean-marc.mac-thiong@umontreal.ca
  • Phone: 514-338-2222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.